Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade
Douglas B. Johnson(Vanderbilt University Medical Center), Christine M. Lovly(Dana-Farber Cancer Institute), Ryan J. Sullivan(Dana-Farber Cancer Institute), Justin Cates(Vanderbilt University Medical Center), Yuting He(Harbin Medical University), Harlan Robins(Adaptive Biotechnologies (United States)), Yaomin Xu(Vanderbilt University Medical Center), James Sun(GlobalFoundries (United States)), Matthew J. Rioth(Vanderbilt University Medical Center), Erik Yusko(Adaptive Biotechnologies (United States)), Dennie T. Frederick(Broad Institute), Igor Puzanov(Roswell Park Comprehensive Cancer Center), Zachary R. Chalmers(Northwestern University), Sohail Balasubramanian(GlobalFoundries (United States)), Yu Shyr(Vanderbilt University), Riley Ennis(GlobalFoundries (United States)), Garrett M. Frampton(Tech Foundation), Jeffrey A. Sosman(Robert H. Lurie Comprehensive Cancer Center of Northwestern University), Xingyi Guo(Vanderbilt University Medical Center), Jeffrey S. Ross(Unknown), Siraj M. Ali(UPMC Hillman Cancer Center), Justin M. Balko(Vanderbilt University Medical Center), Catherine Sanders(Adaptive Biotechnologies (United States)), Vincent A. Miller(Universidad San Carlos), Joel Greenbowe(GlobalFoundries (United States)), Philip J. Stephens(United States Department of the Navy), David Fabrizio(Foundation Medicine (United States))
Cited by 493
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
|Genome Medicine|2017|3.7k